Variant report

Variant	esv1805246
Chromosome Location	chr5:68825844-68923795
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:785)
CpG islands
(count:612)
Chromatin interactive
region (count:5)
LncRNA
region (count:9)
Mature miRNA
region (count: 0)
miRNA target
sites (count:1)

(count:785 , 50 per page) page: 1 2 3 4 5 6 7 ... 16

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BATF	chr5:68897794-68898185	GM12878	blood:	n/a	n/a
2	BATF	chr5:68855769-68856236	GM12878	blood:	n/a	n/a
3	BATF	chr5:68856954-68857395	GM12878	blood:	n/a	n/a
4	BATF	chr5:68855731-68856077	GM12878	blood:	n/a	n/a
5	BATF	chr5:68857142-68857346	GM12878	blood:	n/a	n/a
6	BATF	chr5:68897780-68898118	GM12878	blood:	n/a	n/a
7	BATF	chr5:68856265-68856477	GM12878	blood:	n/a	n/a
8	BCL11A	chr5:68855749-68856242	GM12878	blood:	n/a	chr5:68855979-68855988
9	BCL11A	chr5:68897862-68898148	GM12878	blood:	n/a	n/a
10	BCL11A	chr5:68857029-68857406	GM12878	blood:	n/a	n/a
11	BCL11A	chr5:68855639-68856223	GM12878	blood:	n/a	chr5:68855979-68855988
12	BCL11A	chr5:68897742-68898263	GM12878	blood:	n/a	n/a
13	BCLAF1	chr5:68855724-68856111	K562	blood:	n/a	chr5:68855979-68855988
14	BCLAF1	chr5:68855724-68856116	K562	blood:	n/a	chr5:68855979-68855988
15	BCLAF1	chr5:68855732-68856164	GM12878	blood:	n/a	chr5:68855979-68855988
16	BCLAF1	chr5:68855724-68856135	GM12878	blood:	n/a	chr5:68855979-68855988
17	BHLHE40	chr5:68855820-68856132	HepG2	liver:	n/a	chr5:68855927-68855943 chr5:68855911-68855927
18	BRCA1	chr5:68855848-68856045	Hela-S3	cervix:	n/a	n/a
19	CBX3	chr5:68855493-68856354	K562	blood:	n/a	n/a
20	CBX3	chr5:68855601-68856119	K562	blood:	n/a	n/a
21	CEBPB	chr5:68834691-68834785	HepG2	liver:	n/a	n/a
22	CEBPB	chr5:68855845-68856045	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr5:68857201-68857397	K562	blood:	n/a	n/a
24	CEBPB	chr5:68857055-68857464	K562	blood:	n/a	n/a
25	CEBPB	chr5:68834723-68834923	HepG2	liver:	n/a	n/a
26	CEBPD	chr5:68911591-68912003	K562	blood:	n/a	n/a
27	CEBPD	chr5:68855760-68856284	K562	blood:	n/a	n/a
28	CHD2	chr5:68855923-68856048	GM12878	blood:	n/a	n/a
29	CHD2	chr5:68855853-68856047	Hela-S3	cervix:	n/a	n/a
30	CHD2	chr5:68855844-68855949	H1-hESC	embryonic stem cell:	n/a	n/a
31	CREB1	chr5:68855831-68856118	A549	lung:	n/a	n/a
32	CTCF	chr5:68914417-68914601	A549	lung:	n/a	n/a
33	CTCF	chr5:68855720-68855870	HCT-116	colon:	n/a	n/a
34	CTCF	chr5:68855720-68855870	GM12873	blood:	n/a	n/a
35	CTCF	chr5:68855700-68855850	GM12870	blood:	n/a	n/a
36	CTCF	chr5:68855846-68855989	GM12891	blood:	n/a	n/a
37	CTCF	chr5:68855692-68856174	A549	lung:	n/a	n/a
38	CTCF	chr5:68856000-68856150	HAc	cerebellar:	n/a	n/a
39	CTCF	chr5:68855854-68855949	MCF-7	breast:	n/a	n/a
40	CTCF	chr5:68855980-68856130	HEK293	kidney:	n/a	n/a
41	CTCF	chr5:68855980-68856130	AG10803	skin:	n/a	n/a
42	CTCF	chr5:68856020-68856170	HCM	heart:	n/a	n/a
43	CTCF	chr5:68855720-68855870	GM12867	blood:	n/a	n/a
44	CTCF	chr5:68855720-68855870	BE2_C	brain:	n/a	n/a
45	CTCF	chr5:68855720-68855870	HBMEC	blood vessel:	n/a	n/a
46	CTCF	chr5:68855800-68856092	A549	lung:	n/a	n/a
47	CTCF	chr5:68856020-68856170	HAc	cerebellar:	n/a	n/a
48	CTCF	chr5:68838439-68838481	GM20000	blood:	n/a	n/a
49	CTCF	chr5:68855980-68856130	HRE	kidney:	n/a	n/a
50	CTCF	chr5:68855740-68855890	BE2_C	brain:	n/a	n/a

(count:612 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:68855810-68855860	SAEC	small airway:	n/a
2	chr5:68852996-68853046	Caco-2	colon:	n/a
3	chr5:68855810-68855860	SAEC	small airway:	n/a
4	chr5:68852996-68853046	Caco-2	colon:	n/a
5	chr5:68857760-68857810	NH-A	brain:	n/a
6	chr5:68868293-68868343	A549	lung:	n/a
7	chr5:68855560-68855610	U87	brain:	n/a
8	chr5:68855560-68855610	GM12891	blood:	n/a
9	chr5:68859882-68859932	CMK	blood:	n/a
10	chr5:68856062-68856112	HEEpiC	esophagus:	n/a
11	chr5:68855560-68855610	HRCEpiC	kidney:	n/a
12	chr5:68855873-68855923	ECC-1	luminal epithelium:	n/a
13	chr5:68855560-68855610	RPTEC	kidney:	n/a
14	chr5:68855873-68855923	AG09319	gingival:	n/a
15	chr5:68856062-68856112	HRCEpiC	kidney:	n/a
16	chr5:68855873-68855923	Jurkat	blood:	n/a
17	chr5:68855810-68855860	GM12891	blood:	n/a
18	chr5:68856065-68856115	NHDF-neo	bronchial:	n/a
19	chr5:68852996-68853046	SAEC	small airway:	n/a
20	chr5:68856077-68856127	Hela-S3	cervix:	n/a
21	chr5:68855873-68855923	SAEC	small airway:	n/a
22	chr5:68855560-68855610	PFSK-1	brain:	n/a
23	chr5:68856077-68856127	SK-N-MC	brain:	n/a
24	chr5:68855873-68855923	SK-N-SH_RA	brain:	n/a
25	chr5:68857760-68857810	HRCEpiC	kidney:	n/a
26	chr5:68855810-68855860	HCF	heart:	n/a
27	chr5:68856065-68856115	MCF-7	breast:	n/a
28	chr5:68855810-68855860	A549	lung:	n/a
29	chr5:68856065-68856115	AG04449	skin:	fetal
30	chr5:68852996-68853046	PFSK-1	brain:	n/a
31	chr5:68856077-68856127	AG04449	skin:	fetal
32	chr5:68855873-68855923	MCF-7	breast:	n/a
33	chr5:68856077-68856127	HAEpiC	amniotic membrane:	n/a
34	chr5:68859882-68859932	NH-A	brain:	n/a
35	chr5:68856077-68856127	HNPCEpiC	eye:	n/a
36	chr5:68855873-68855923	HPAEpiC	pulmonary alveolar:	n/a
37	chr5:68852996-68853046	ovcar-3	ovarian:	n/a
38	chr5:68856065-68856115	NT2-D1	testis:	n/a
39	chr5:68857760-68857810	GM12878	blood:	n/a
40	chr5:68856062-68856112	SKMC	muscle:	n/a
41	chr5:68859882-68859932	Hela-S3	cervix:	n/a
42	chr5:68868293-68868343	NHDF-neo	bronchial:	n/a
43	chr5:68868293-68868343	AG09309	skin:	n/a
44	chr5:68855873-68855923	K562	blood:	n/a
45	chr5:68852996-68853046	AoSMC	blood vessel:	n/a
46	chr5:68855810-68855860	Hepatocyte	liver:	n/a
47	chr5:68856062-68856112	ProgFib	skin:	n/a
48	chr5:68855873-68855923	HL-60	blood:	n/a
49	chr5:68856065-68856115	HNPCEpiC	eye:	n/a
50	chr5:68855810-68855860	MCF-7	breast:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr5:68711082..68712894-chr5:68825364..68828331,2	MCF-7	breast:
2	chr5:68787211..68792044-chr5:68819088..68825852,9	MCF-7	breast:
3	chr5:68791729..68794377-chr5:68827769..68829901,2	MCF-7	breast:
4	chr5:68786843..68790127-chr5:68821932..68828319,7	MCF-7	breast:
5	chr5:68811437..68815245-chr5:68822688..68826346,4	MCF-7	breast:

(count:9 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-TAF9-6	chr5:68921203-68921727	NONHSAT101933
2	lnc-OCLN-1	chr5:68856086-68856428	NONHSAT101929
3	lnc-OCLN-1	chr5:68860927-68860960	NONHSAT101929
4	lnc-GTF2H2C-2	chr5:68914140-68914221	NONHSAT101932
5	lnc-GTF2H2C-1	chr5:68889300-68889532	NONHSAT101931
6	lnc-OCLN-1	chr5:68858500-68858597	NONHSAT101929
7	lnc-GTF2H2C-2	chr5:68915841-68915892	NONHSAT101932
8	lnc-GTF2H2C-2	chr5:68914878-68915107	NONHSAT101932
9	lnc-GTF2H2C-1	chr5:68890071-68890550	NONHSAT101931

No data

(count:1 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	GTF2H2D	hsa-miR-30a-5p	chr5:68888221-68888242

Variant related genes	Relation type
GTF2H2C	TF binding region
RNU6-724P	TF binding region
ENSG00000238740	TF binding region
OCLN	TF binding region
ENSG00000248477	TF binding region
ENSG00000250138	TF binding region
GTF2H2C	CpG island
RNU6-724P	CpG island
ENSG00000238740	CpG island
OCLN	CpG island
ENSG00000248477	CpG island
ENSG00000250138	CpG island
ENSG00000197822	chromatin interactions
ENSG00000152939	chromatin interactions

Extended variants
information (count: 750 )
Associated
traits (count: 115 )

Variant overlapped rSNPs/rCNVs (count:750 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs116382845	chr5:68825923-68825924	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs566008536	chr5:68825938-68825939	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs189836689	chr5:68825997-68825998	Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs539742009	chr5:68826000-68826001	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs34582817	chr5:68826013-68826014	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs61396502	chr5:68826041-68826042	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs556120477	chr5:68826091-68826092	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs143910079	chr5:68826100-68826101	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs537201404	chr5:68826155-68826156	Weak transcription Enhancers Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs555190654	chr5:68826217-68826218	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs79372623	chr5:68826246-68826247	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs540701859	chr5:68826247-68826248	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs558903871	chr5:68826258-68826259	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs578028711	chr5:68826300-68826301	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs34263306	chr5:68826322-68826323	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs542439051	chr5:68826345-68826346	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs200184453	chr5:68826446-68826447	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs147282148	chr5:68826487-68826488	Enhancers Weak transcription Genic enhancers	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs567650903	chr5:68826599-68826600	Enhancers Weak transcription Genic enhancers	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs148293718	chr5:68826676-68826677	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs531016361	chr5:68826709-68826710	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs577474014	chr5:68826774-68826775	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs28703202	chr5:68826788-68826789	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	mRNA abundance
24	rs77144436	chr5:68826797-68826798	Enhancers Weak transcription Flanking Active TSS Genic enhancers Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs543264457	chr5:68826822-68826823	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs180972917	chr5:68826825-68826826	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs561159751	chr5:68826861-68826862	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs77360756	chr5:68826991-68826992	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs113255634	chr5:68827069-68827070	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs538992553	chr5:68827077-68827078	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs551703412	chr5:68827108-68827109	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs76142857	chr5:68827152-68827153	Enhancers Weak transcription Genic enhancers Flanking Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs536866592	chr5:68827336-68827337	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs555519792	chr5:68827481-68827482	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs573685395	chr5:68827532-68827533	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs534714628	chr5:68827557-68827558	Weak transcription Enhancers Genic enhancers Flanking Active TSS	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs552593157	chr5:68827606-68827607	Weak transcription Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs577229717	chr5:68827634-68827635	Weak transcription Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs186399110	chr5:68827757-68827758	Weak transcription Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs192158883	chr5:68827780-68827781	Weak transcription Enhancers Flanking Active TSS Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs73118806	chr5:68827908-68827909	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs542887656	chr5:68827984-68827985	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs28376467	chr5:68828025-68828026	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs528617864	chr5:68828043-68828044	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs372628390	chr5:68828070-68828071	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs561014337	chr5:68828118-68828119	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs547124095	chr5:68828126-68828127	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs115136357	chr5:68828186-68828187	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs532570503	chr5:68828221-68828222	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs550958047	chr5:68828236-68828237	Weak transcription Enhancers Strong transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:115)

Disease	PMID	Source
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Multiple myeloma	17550852	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ovarian cancer	21781307	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Cancer	16751803	CNVD
Intellectual disability	22102821	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Breast cancer	17603634	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Breast cancer	22032731	CNVD
Prostate cancer	21965145	CNVD
Esophageal cancer	20955586	CNVD
Congenital anomalies of the kidney and urinary tract	18694510	CNVD
Ovarian cancer	20844748	CNVD
Breast cancer	17393978	CNVD
Cancer	21359685	CNVD
Non-small cell lung cancer	21829676	CNVD
adenomatous polyposis	22470819	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Hepatocellular carcinoma	16750200	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Oral cancer	21386901	CNVD
Bladder cancer	21909424	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17133270	CNVD
Breast cancer	19602461	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Retinoblastoma	22278416	CNVD
Bipolar disorder	18458673	CNVD
Thyroid cancer	19087340	CNVD
abnormal development	18461090	CNVD
Merkel cell carcinoma	19020549	CNVD
Squamous cell cancer	20885788	CNVD
Neurodevelopmental disorder	22521361	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Breast cancer	21045282	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Myelodysplastic syndrome	18663149	CNVD
Spinal muscular atrophy	15981080	CNVD
Spinal muscular atrophy	18839960	CNVD
Spinal muscular atrophy	19716110	CNVD
Sezary syndrome	18413736	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	21990379	CNVD
Hirschsprung''s Disease	21712996	CNVD
Apoptosis	19488400	CNVD
Breast cancer	22048815	CNVD
Myelofibrosis	22110671	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Acute monocytic leukemia	16498392	CNVD
Colorectal cancer	20459617	CNVD
Gastric adenocarcinoma	19115996	CNVD
Spinal muscular atrophy	17160897	CNVD
Spinal muscular atrophy	17668391	CNVD
Spinal muscular atrophy	17668395	CNVD
Glioblastoma multiforme	22286061	CNVD
craniofacial dysmorphism	21918468	CNVD
Multiple myeloma	16616336	CNVD
Prostate cancer	16461572	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Pseudo-TORCH syndrome	20727516	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD
Autism	21865298	CNVD
Medullary thyroid carcinoma	18765511	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Obesity	21131291	CNVD
early-passage human iPS cells	21368824	CNVD
Breast cancer	21364760	CNVD

Chromatin state (count:440 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:68805600-68826200	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
2	chr5:68805600-68826600	Weak transcription	Breast Myoepithelial Primary Cells	Breast
3	chr5:68806400-68826400	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr5:68815400-68826600	Weak transcription	Pancreatic Islets	Pancreatic Islet
5	chr5:68815800-68831000	Weak transcription	HepG2	liver
6	chr5:68817200-68827200	Weak transcription	GM12878-XiMat	blood
7	chr5:68821800-68830800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
8	chr5:68822200-68826800	Weak transcription	Lung	lung
9	chr5:68822400-68829400	Weak transcription	Fetal Stomach	stomach
10	chr5:68822600-68826200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
11	chr5:68822800-68826400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr5:68822800-68826800	Weak transcription	Gastric	stomach
13	chr5:68822800-68828000	Weak transcription	Liver	Liver
14	chr5:68823600-68829200	Weak transcription	Sigmoid Colon	Sigmoid Colon
15	chr5:68823800-68826600	Weak transcription	Pancreas	Pancrea
16	chr5:68824000-68826000	Weak transcription	Rectal Mucosa Donor 29	rectum
17	chr5:68824000-68827000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
18	chr5:68824000-68830600	Weak transcription	HUES64 Cell Line	embryonic stem cell
19	chr5:68824000-68855400	Weak transcription	iPS-20b Cell Line	embryonic stem cell
20	chr5:68824200-68826600	Weak transcription	Duodenum Mucosa	Duodenum
21	chr5:68824200-68829600	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
22	chr5:68824400-68826000	Weak transcription	Rectal Mucosa Donor 31	rectum
23	chr5:68824400-68826200	Weak transcription	Stomach Mucosa	stomach
24	chr5:68824400-68832400	Weak transcription	HUES6 Cell Line	embryonic stem cell
25	chr5:68824800-68826600	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
26	chr5:68824800-68827000	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
27	chr5:68825200-68826400	Weak transcription	HUES48 Cell Line	embryonic stem cell
28	chr5:68825200-68826800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
29	chr5:68825200-68827200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
30	chr5:68825600-68826000	Weak transcription	Fetal Intestine Large	intestine
31	chr5:68825800-68827600	Genic enhancers	Fetal Intestine Small	intestine
32	chr5:68826000-68826600	Enhancers	Rectal Mucosa Donor 29	rectum
33	chr5:68826000-68827200	Enhancers	Fetal Intestine Large	intestine
34	chr5:68826000-68827600	Enhancers	Rectal Mucosa Donor 31	rectum
35	chr5:68826000-68828200	Enhancers	Cortex derived primary cultured neurospheres	brain
36	chr5:68826200-68827000	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
37	chr5:68826200-68827200	Enhancers	ES-I3 Cell Line	embryonic stem cell
38	chr5:68826200-68827800	Enhancers	Stomach Mucosa	stomach
39	chr5:68826400-68826600	Enhancers	Primary neutrophils fromperipheralblood	blood
40	chr5:68826400-68826800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
41	chr5:68826400-68827200	Enhancers	Primary monocytes fromperipheralblood	blood
42	chr5:68826400-68827200	Enhancers	Primary hematopoietic stem cells short term culture	blood
43	chr5:68826400-68827800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
44	chr5:68826600-68826800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
45	chr5:68826600-68826800	Active TSS	Pancreatic Islets	Pancreatic Islet
46	chr5:68826600-68827200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
47	chr5:68826600-68827400	Enhancers	Duodenum Mucosa	Duodenum
48	chr5:68826600-68827600	Enhancers	Breast Myoepithelial Primary Cells	Breast
49	chr5:68826600-68827800	Enhancers	Brain Anterior Caudate	brain
50	chr5:68826600-68827800	Enhancers	Brain Hippocampus Middle	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links